Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Joeri Kint"'
Autor:
Claudio Counoupas, Paco Pino, Alberto O. Stella, Caroline Ashley, Hannah Lukeman, Nayan D. Bhattacharyya, Takuya Tada, Stephanie Anchisi, Charles Metayer, Jacopo Martinis, Anupriya Aggarwal, Belinda M. Dcosta, Warwick J. Britton, Joeri Kint, Maria J. Wurm, Nathaniel R. Landau, Megan Steain, Stuart G. Turville, Florian M. Wurm, Sunil A. David, James A. Triccas
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT Global control of COVID-19 will require the deployment of vaccines capable of inducing long-term protective immunity against SARS-CoV-2 variants. In this report, we describe an adjuvanted subunit candidate vaccine that affords elevated, sust
Externí odkaz:
https://doaj.org/article/215dbedfcba04207b2b7b97f024ad384
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/d3f97aa75a69471e8dffc24d70f6bb16
Autor:
Christopher L. D. McMillan, Armira Azuar, Jovin J. Y. Choo, Naphak Modhiran, Alberto A. Amarilla, Ariel Isaacs, Kate E. Honeyman, Stacey T. M. Cheung, Benjamin Liang, Maria J. Wurm, Paco Pino, Joeri Kint, Germain J. P. Fernando, Michael J. Landsberg, Alexander A. Khromykh, Jody Hobson-Peters, Daniel Watterson, Paul R. Young, David A. Muller
Publikováno v:
Vaccines, Vol 10, Iss 4, p 578 (2022)
The ongoing coronavirus disease 2019 (COVID-19) pandemic continues to disrupt essential health services in 90 percent of countries today. The spike (S) protein found on the surface of the causative agent, the SARS-CoV-2 virus, has been the prime targ
Externí odkaz:
https://doaj.org/article/047b2bd3483b4cd9b6da0a66f2543ada
Autor:
Anna Lundin, Ronald Dijkman, Tomas Bergström, Nina Kann, Beata Adamiak, Charles Hannoun, Eveline Kindler, Hulda R Jónsdóttir, Doreen Muth, Joeri Kint, Maria Forlenza, Marcel A Müller, Christian Drosten, Volker Thiel, Edward Trybala
Publikováno v:
PLoS Pathogens, Vol 10, Iss 5, p e1004166 (2014)
Coronaviruses raise serious concerns as emerging zoonotic viruses without specific antiviral drugs available. Here we screened a collection of 16671 diverse compounds for anti-human coronavirus 229E activity and identified an inhibitor, designated K2
Externí odkaz:
https://doaj.org/article/c8481c7f14ad4444af2631693445ff2f
Autor:
Helen M. E. Duyvesteyn, Joel D. Allen, Yasunori Watanabe, Peter J. Bond, David I. Stuart, Philip J. M. Brouwer, Himanshi Chawla, Dennis R. Burton, Tomas Malinauskas, Sean Callaghan, Paco Pino, Yongfei Cai, Sai Li, Martin Frank, Maria J Wurm, Bing Chen, Aishwary Tukaram Shivgan, Yutong Song, Peter Yong, Wan-ting He, Joeri Kint, Raiees Andrabi, Max Crispin, Ge Song, Firdaus Samsudin, Rogier W. Sanders, Lorena Zuzic
Publikováno v:
Biochemistry
Martin Frank
bioRxiv
Martin Frank
bioRxiv
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike protein is a potential source of heterogeneity between the many
Autor:
Florian M. Wurm, Paco Pino, Stuart Turville, Maria J Wurm, Megan Steain, Charles Metayer, Jacopo Martinis, Sunil A. David, Claudio Counoupas, Alberto Ospina Stella, Caroline L. Ashley, James A. Triccas, Anupriya Aggarwal, Hannah Lukeman, Nayan D. Bhattacharyya, Joeri Kint, Nathaniel R. Landau, Takuya Tada, Belinda M Dcosta, Stephanie Anchisi
Global control of COVID-19 will require the deployment of vaccines capable of inducing long-term protective immunity against SARS-CoV-2 variants. In this report, we describe an adjuvanted subunit candidate vaccine that affords elevated, sustained and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1ea13ff50cd9148d7ecbb3ba3cb489
https://hdl.handle.net/2123/26142
https://hdl.handle.net/2123/26142
Autor:
Paco Pino, Paolo Rovero, Andrey V. Kajava, Patrick O. Byrne, Gerco den Hartog, Giampietro Corradin, Divor Kiseljak, Maria J Wurm, Jason S. McLellan, Joeri Kint, Ronald Dijkman, Florian M. Wurm, Valentina Agnolon
The Spike protein of SARS-CoV-2 is essential for virus entry into human cells. In fact, most neutralizing antibodies against SARS-CoV-2 are directed against the Spike, making it the antigen of choice for use in vaccines and diagnostic tests. In the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c4c9b50afbc4cb1a8fad1b6722e3b0
https://doi.org/10.1101/2020.11.15.382044
https://doi.org/10.1101/2020.11.15.382044
Autor:
Jasmin Kutter, Geert F. Wiegertjes, Joeri Kint, Helena J. Maier, Jelke J. Fros, Gorben P. Pijlman, Joseph Koumans, Maria Forlenza, Annemiek Dickhout, Paul Britton
Publikováno v:
Journal of Virology
Journal of Virology, 89(23), 12047-12057
Journal of Virology 89 (2015) 23
Journal of Virology, 89(23), 12047-12057. American Society for Microbiology
Journal of Virology, 89(23), 12047-12057
Journal of Virology 89 (2015) 23
Journal of Virology, 89(23), 12047-12057. American Society for Microbiology
The innate immune response is the first line of defense against viruses, and type I interferon (IFN) is a critical component of this response. Similar to other viruses, the gammacoronavirus infectious bronchitis virus (IBV) has evolved under evolutio
Autor:
Bas van de Waterbeemd, Johannes Tramper, E. Coen Beuvery, Dirk E. Martens, Mathieu Streefland, Joeri Kint, Leo A. van der Pol
Publikováno v:
Biotechnology and Bioengineering 102 (2009) 1
Biotechnology and Bioengineering, 102(1), 161-167
Biotechnology and Bioengineering, 102(1), 161-167
Modern (bio)pharmaceutical process development requires thorough investigation of all process parameters that are critical to product quality. The impact of a disturbance of such a parameter during processing needs to be known so that a rational deci
Autor:
Maria Forlenza, Joeri Kint
Publikováno v:
Coronaviruses ISBN: 9781493924370
Coronaviruses: Methods and Protocols
Coronaviruses: Methods and Protocols. Springer
Coronaviruses: Methods and Protocols
Coronaviruses: Methods and Protocols. Springer
Activation of the type I interferon (IFN) response is an essential defense mechanism against invading pathogens such as viruses. This chapter describes two protocols to quantify activation of the chicken IFN response through analysis of gene expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7364421eeacb184b2a17c0b53dd0fdcc
https://doi.org/10.1007/978-1-4939-2438-7_21
https://doi.org/10.1007/978-1-4939-2438-7_21